Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01586819 · ClinicalTrials.gov registry record · Phase 3
Lateral Canthal Rhytides With Medium Depth Chemical Peel With or Without Pretreatment With Botulinum Toxin A
A Phase 3 study, sponsored by Loyola University.
- Completed
- Registry status
- Phase 3
- Development phase
- 26
- Enrollment target
NCT01586819 is a Phase 3 study that has completed, run by Loyola University. The registered enrollment target is 26 participants.
The verdict
NCT01586819, a Phase 3 study, has completed, sponsored by Loyola University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 26 participants
- Enrollment target
Study Summary
This study is being done to find out if the use of botulinum toxin prior to a medium strength combination chemical peel (Jessner's peel followed by 35% Trichloroacetic acid peel) will improve the appearance of crow's feet wrinkles when compared to a chemical peel alone. Botulinum toxin type A is a purified substance, derived from a bacteria that block muscular nerve signals. Jessner's Peel, a combination of resorcinol (14g), salicylic acid (14g), and lactic acid (85%) in ethanol (95%), is a superficial chemical peel. These two products/procedures have been FDA approved to improve the appearance of facial wrinkles.
Interventions
- DRUG Botulinum Toxin
- PROCEDURE Chemical Peel Only
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2011-09 |
| Est. Completion | 2013-05 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01586819
The ClinicalTrials.gov registry entry for NCT01586819 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Loyola University, which has 92 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Botulinum Toxin is the first listed.
NCT01586819 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01586819 about?
NCT01586819 is a clinical study titled "Lateral Canthal Rhytides With Medium Depth Chemical Peel With or Without Pretreatment With Botulinum Toxin A". This study is being done to find out if the use of botulinum toxin prior to a medium strength combination chemical peel (Jessner's peel followed by 35% Trichloroacetic acid peel) will improve the appearance of crow's feet wrinkles when compared to a chemical peel alone. Botulinum toxin type A is a p...
What is the current status of trial NCT01586819?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 26 participants. The study started on 2011-09. Estimated completion is 2013-05.
What interventions are being tested in trial NCT01586819?
The interventions under investigation include: Botulinum Toxin (DRUG), Chemical Peel Only (PROCEDURE).
Who is sponsoring clinical trial NCT01586819?
This trial is sponsored by Loyola University, which has 92 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.